Preparation and evaluation of transdermal patches of metformin hydrochloride using natural polymer for sustained release

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 297-302

  Allena, Ravi Teja ^a   Yadav, Hemant K S ^a   Sandina, Swetha ^a   Sarat Chandra Prasad, M ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Chitosan; HPMC; Metformin HCl; Solvent evaporation method

Indexed keywords

CHITOSAN; HYDROXYPROPYLMETHYLCELLULOSE; METFORMIN;

ARTICLE; DRUG DETERMINATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; INFRARED SPECTROPHOTOMETRY; MOISTURE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TENSILE STRENGTH; TRANSDERMAL PATCH; WATER VAPOR;

EID: 84862636320     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. d ed, 50: 301-375.
2. Louis S Goodman; Laurence L Brunton, Goodman & Gilmans. The pharmacological basis of therapeutics, McGraw-Hill Medical, New York, 2005; (11): 1613-1638.
3. Mary Anne Koda-Kimble, Llyod Yee Young, Applied Therapeutics, The clinical use of Drugs, Lippincott Williams, USA, 2009; 9: 502-503.
4. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update) London: Royal College of Physicians 2008; ISBN 9781860163333, 86.
5. th ed: 1638-1639.
6. Dey BK, Kar PK and Nath LK. Formulation design, preparation and in vitro-in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex. Research J. Pharm. and Tech. 2009; 2(1): 155-60.
7. R. Herrman, Bioequivalence of a nifedipine extended release formulation compared to a standard formulation in steady state, Arzneimittel-Forschung, 1988; 46, 28.
8. Arora P. Mukherjee B. Design development of physicochemical in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. Indian J. Pharm. Sci. 2002; 91(9): 2076-89.
9. Kevin c. Garala, anil j. Shinde, pratik h. Shah. Formulation and in-vitro characterization of monolithic matrix Transdermal systems using HPMC/Eudragit s 100 polymer blends, Int J Pharmacy and Pharmaceutical Sciences 2009; 1(1): 108-120.
10. Gupta R, Bajpal M and Bhattacharya A. Formulation and in vitro Evaluation of transdermal drug delivery system of tizanidine hydrochloride, Indian J. Pharm. Sci. 2008; 7(4): 208-13.
11. Sankar V, Benito DJ, Sivanand V, Ravichandran V, Velrajan G and Raghuraman S. Design and evaluation of nifedipine transdermal patches. Indian J. Pharm. Sci. 2003; 65(5): 510-15.
12. Sathyapriya, L.S., Jayaprakash, S., Prabhu, R.S., Abirami, A., Subramanian, K., Nagarajan, M., Int J Pharm Sci Tech 2008; 1: 22-28.
13. Saxena M, Mutalik S and Reddy MS. Formulation and evaluation of transdermal patches of metoclopramide hydrochloride, Indian Drugs. 2006; 43(9): 740-45.
14. Gupta SP and Jain SK. Effective and controlled transdermal delivery of metoprolol tartarate. Indian J. Pharm. Sci. 2005; 67(3): 346-350.
15. D. Thacharodi and K. Panduranga Rao. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride, Biomaterials. 1995; 16(2): 145-148.
16. Khan GM. Controlled Release Oral Dosage Forms: Some recent, advances in matrix type drug delivery systems. The Sciences. 2001; (1): 350-354.
17. Morkhade DM, Fulzele SV, Stturwar PM and Joshi SB. Gum copal and gum damar: novel matrix forming materials for sustained drug delivery. Ind. J. Pharm. Sci. 2006; 68: 53-58.
18. Higuchi T. Mechanism of rate of sustained-action medication. J. Pharm. Sci. 1963; 52: 1145-1149.
19. Peppas NA and Sahlin JJ. A simple equation for the description of solute release III.5 Coupling of diffusion and relaxation. Int. J. Pharm. 1989; 57: 169-172.